CRDF · Cardiff Oncology, Inc.
$0.81
-0.01 (-0.98%)
At close · Jul 29
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has performed an analysis and concluded that there exists a substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$55.38M
Shares
68.37M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2014-03-31 | $500,000 | 10-Q, filed 2014-05-12 |
| 2013-12-31 | $500,000 | 10-K, filed 2014-03-17 |
| 2013-09-30 | $500,000 | 10-Q, filed 2013-11-14 |
| 2013-06-30 | $500,000 | 10-Q, filed 2013-08-14 |
| 2013-03-31 | $500,000 | 10-Q, filed 2013-05-14 |
| 2012-12-31 | $500,000 | 10-K, filed 2013-04-01 |
| 2012-09-30 | $500,000 | 10-Q, filed 2012-11-14 |
| 2012-06-30 | $500,000 | 10-Q, filed 2012-08-14 |
| 2012-03-31 | $500,000 | 10-Q, filed 2012-05-15 |
Key facts
CIK
1213037
CUSIP
14147L108
13F (30d)
23 filings
23 filers
Visit website
Investor relations